Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia

Published:2018-04-03 Issue:4 Volume:27 Page:377-387
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Bartaula-Brevik Sushma¹,Lindstad Brattås Marte Karen²,Tvedt Tor Henrik Anderson¹³,Reikvam Håkon¹³,Bruserud Øystein¹³

Affiliation:

1. Section for Hematology, Department of Clinical Science, University of Bergen, Bergen, Norway

2. Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway

3. Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway

Funder

Helse-Vest

Kreftforeningen

Eivind Møllbach Pedersens Foundation

Universitetet i Bergen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2018.1459562

Reference97 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

3. Inflammasome: Putting the Pieces Together

4. The SYK tyrosine kinase: a crucial player in diverse biological functions

5. The osteoclast and its unique cytoskeleton

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents;Expert Opinion on Investigational Drugs;2024-08-11

2. Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK);Bioorganic & Medicinal Chemistry;2023-12

3. Exploring molecular interactions of potential inhibitors against the spleen tyrosine kinase implicated in autoimmune disorders via virtual screening and molecular dynamics simulations;SAR and QSAR in Environmental Research;2023-10-26

4. Discovery of 3-(1H-benzo[d]imidazole-2-yl)-1H-pyrazol-4 -amine derivatives as novel and potent syk inhibitors for the treatment of hematological malignancies;European Journal of Medicinal Chemistry;2023-10

5. The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications;Molecular Cancer;2023-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3